Clinical predictors of different grades of nonalcoholic fatty liver disease

Obesity Surgery

Volumn 22, Issue 2, 2012, Pages 248-252

  Júnior, Wilson Salgado ^a   Nonino Borges, Carla Barbosa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Nonalcoholic fatty liver disease; Obesity; Predictors

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INTERLEUKIN 1; INTERLEUKIN 6; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; SENSITIVITY AND SPECIFICITY; STOMACH BYPASS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANALYSIS OF VARIANCE; BARIATRIC SURGERY; BIOPSY; BODY MASS INDEX; COHORT STUDIES; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; MEDICAL RECORDS; OBESITY, MORBID; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84857362342     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-011-0438-6     Document Type: Article

References (19)

1. JB Dixon PS Bhathal PE O'Brien 2001 Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese Gastroenterology 121 91 100 11438497 10.1053/gast.2001.25540 1:CAS:528:DC%2BD3MXlt1ykt70%3D (Pubitemid 32591518)
2. P Angulo 2002 Nonalcoholic fatty liver disease N Engl J Med 18 1221 31 10.1056/NEJMra011775 (Pubitemid 34984585)
3. WI Youssef AJ McCullough 2002 Steatohepatitis in obese individuals Best Pract & Resear Clin Gastroenterol 16 733 47 10.1053/bega.2002.0334
4. SA Harrison S Torgerson PH Hayashi 2003 The natural history of nonalcoholic fatty liver disease: a clinical histopathological study Am J Gastroenterol 98 2042 7 14499785 10.1111/j.1572-0241.2003.07659.x (Pubitemid 37185803)
5. IN Guha J Parkes P Roderick, et al. 2008 Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers Hepatology 47 455 60 18038452 10.1002/hep.21984 (Pubitemid 351280713)
6. BR Bacon MJ Farahvash CG Janney BA Neuschwander-Tetri 1994 Nonalcoholic steatohepatitis: an expanded clinical entity Gastroenterology 107 1103 1109 7523217 1:STN:280:DyaK2M%2FhtFansw%3D%3D (Pubitemid 24294573)
7. EE Powell WG Cooksley R Hanson J Searle JW Halliday LW Powell 1990 The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years HEPATOLOGY 11 74 80 2295475 10.1002/hep.1840110114 (Pubitemid 20075105)
8. V Ratziu P Giral F Charlotte E Bruckert V Thibault I Theodorou L Khalil, et al. 2000 Liver fibrosis in overweight patients Gastroenterology 118 1117 1123 10833486 10.1016/S0016-5085(00)70364-7 1:STN:280:DC%2BD3c3psFSntg%3D%3D (Pubitemid 30346988)
9. EM Brunt CG Janney AM Di Bisceglie, et al. 1999 Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 2467 74 10484010 10.1111/j.1572-0241.1999.01377.x 1:STN:280:DyaK1MvhtFyisw%3D%3D (Pubitemid 29420675)
10. B Degertekin S Ozenirler S Elbeg G Akyol 2007 The serum endothelin- 1 level in steatosis and NASH, and its relation with severity of liver fibrosis Dig Dis Sci 52 10 2622 8 17429733 10.1007/s10620-006-9147-8 1:CAS:528: DC%2BD2sXhtVSisLvI (Pubitemid 47373869)
11. A Suzuki P Angulo J Lymp D Li S Satomura K Lindor 2005 Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease Liver Int 25 4 779 86 15998429 10.1111/j.1478-3231.2005.01064.x 1:CAS:528:DC%2BD2MXpsVantrs%3D (Pubitemid 41038659)
12. A Wieckowska NN Zein LM Yerian AR López AJ McCullough AE Feldstein 2006 In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease Hepatology 44 1 27 33 16799979 10.1002/hep.21223 1:CAS:528:DC%2BD28XnsFWjtrs%3D (Pubitemid 44049136)
13. M Kukla KZ Korczala M Hartleb, et al. 2010 Serum chemerin and vaspin in non-alcoholic fatty liver disease Scandinavian Journal of Gastroenterology 45 235 242 20095887 10.3109/00365520903443852 1:CAS:528:DC%2BC3cXht1Smsbc%3D
14. M Yoneda H Mawatari K Fujita H Endo H Iida Y Nozaki, et al. 2008 Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD) Dig Liver Dis 40 5 371 8 18083083 10.1016/j.dld.2007.10.019 1:CAS:528:DC%2BD1cXns1yhsLc%3D
15. S Saadeh ZM Younosi EM Rener, et al. 2002 The utility of radiological imaging in nonalcoholic fatty liver desease Gastroenterology 123 745 50 12198701 10.1053/gast.2002.35354 (Pubitemid 34977081)
16. D Joy VR Thava BB Scott 2003 Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 15 539 43 12702913 (Pubitemid 36571048)
17. P Angulo JC Keach KP Batts, et al. 1999 Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 30 1356 62 10573511 10.1002/hep.510300604 1:STN:280:DC%2BD3c%2Fkt1ejtQ%3D%3D
18. SA Harrison D Oliver HL Arnold, et al. 2008 Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease Gut 57 1441 7 18390575 10.1136/gut.2007.146019 1:STN:280:DC%2BD1crpvF2isA%3D%3D
19. GM Campos K Bambha E Vittinghoff, et al. 2008 A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients Hepatology 47 1916 23 18433022 10.1002/hep.22241 (Pubitemid 351945559)